Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Freund-Michel, F. Laroumanie, M. Salagiesrka, M. Dubois, A. Courtois, M. Autissier, C. Guibert, J. P. Savineau, R. Marthan, B. Muller (Bordeaux, France). Nerve growth factor expression and function in pulmonary arterial hypertension. Eur Respir J 2010; 36: Suppl. 54, 1080

Member's Comments

No comment yet.

Related content which might interest you: Potential role of the nerve growth factor NGF in pulmonary arterial hypertension Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH) Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Role of Connexin 43 increased expression in pulmonary arterial hyperreactivityinduced by the nerve growth factor NGF Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Expression and role of the nerve growth factor NGF in pulmonary hypertension Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension Year: 2011 Expression and functional analysis of the transforming growth factor (TGF)-β superfamily in pulmonary arterial hypertension: role of PAI-1 in disease progression Source: Eur Respir J 2007; 30: Suppl. 51, 53s Year: 2007 Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 The transforming growth factor-β/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension Source: Eur Respir J 2007; 29: 1094-1104 Year: 2007 Insulin-like growth factor-1 contributes to the pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Bone morphogenetic protein receptor-II as a regulator of pulmonary artery endothelial cell permeability: Relevance to the initiation and progression of heritable pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Vascular endothelial growth factor levels in active pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 610s Year: 2002 Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Possible role of imatinib in clinical pulmonary veno-occlusive disease Source: Eur Respir J 2008; 32: 232-235 Year: 2008 Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis? Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension Source: Eur Respir J 2009; 34: 662 Year: 2009 VEGF reduces pulmonary hypertension and vascular remodeling in pulmonary fibrosis through reduced endothelial apoptosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007